Skip to main content
2025 RAPS European Clinical & Risk Mngmt Conf. Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.

Closing Plenary: The Holy Trinity of the MDR – Risk management, Clinical Evaluation and PMS

Thursday, October 24, 2024
3:15 PM - 4:15 PM CEST
Location/Room: Sagrada familia - 4th fl

Description:

In the realm of medical device regulatory affairs, the seamless convergence of risk management, clinical evaluation, and post-market surveillance is key. Without it, we'll continue with inconsistencies, lack of solid evidence and frustrated colleagues. The known consequences: many questions from conformity assessment bodies and delay in market approval.

So – how to improve the communications within your company from regulatory perspective?
This session builds on the lessons learned over the years, expands on the session from RAPS Euro Convergence and focusses on encapsulation of the importance of synergy, uniting experts and stakeholders to discuss the current obstacles and shine a light on the industry's current needs.
We'll focus on the results of two days of conference on risk management, clinical evaluation and PMS, and will look for establishing ground for a unified interface. Discover how this synergy enhances safety, efficacy, and compliance, benefiting patients and advancing the industry.